Accipiter Biosciences logo

Accipiter Biosciences

accipiterbio.com

Accipiter Biosciences uses computational protein design to develop de novo protein therapies that engage multiple cell-surface receptors and pathways in one stable molecule. Its therapies are designed for complex diseases, including autoimmune disorders and cancer, as an alternative to combination treatments.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
26
Registered name
Accipiter Biosciences Inc Seattle business license
Stage
Seed
Members see funding amounts.
.

Is this your organization? Claim it

Accipiter Bio raises $10.5M more to speed AI-designed multi-target protein drugs, expanding clinical pipeline

Seattle biotech Accipiter Bio raised an additional $10.5 million from existing investors to accelerate development of AI-designed multi-target protein therapeutics and expand its team and clinical pipeline. The company, now 22 people strong and partnered with Pfizer and Kite/Gilead, will use the funds to advance three to four programs—focusing mainly on immunology alongside oncology—after emerging from stealth last year with $12.7 million.

Bill Gates-Backed Modern Hydrogen Lays Off Most Employees; TerraPower Gets NRC Nod for First Nuclear Plant

GeekWire's most popular stories for the week of Nov. 30, 2025 include Bill Gates-backed Modern Hydrogen laying off most staff due to funding changes, TerraPower receiving NRC approval for a nuclear plant, and new AI advancements in protein design from University of Washington. Other highlights include Amazon launching a 30-minute delivery service, discussions on a proposed Washington payroll tax affecting tech companies, and debates about Seattle's attitude toward AI.

See all 4 stories, episodes and videos about Accipiter Biosciences.

People

See all 4
  • Matthew Bick
    Matthew Bick co-founder and Chief Executive Officer
  • Hector Rincon-Arano Co-founder and Chief Scientific Officer
  • Javier Castellanos Co-founder and Chief Technology Officer

Online